Takeda Chief Transformation Officer Lauren Duprey Sells $640K in ADSs
TAKEDA PHARMACEUTICAL CO LTD
Subscribe to track TAK
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
Insider Sale Alert: TAKEDA PHARMACEUTICAL CO LTD ($TAK) • Insider: Duprey Lauren Rusckowski (Chief Transformation Officer) • Transaction: Sold 34,535 ADSs @ $18.54 per share • Total Value: $640,278.90 • Shares Remaining: 191,522 ADSs • Filing Date: September 15, 2026
Comprehensive Analysis
Executive Summary
On September 14, 2026, Lauren Rusckowski Duprey, Chief Transformation Officer of Takeda Pharmaceutical Co Ltd ($TAK), executed an open-market sale of 34,535 American Depositary Shares (ADSs) at an average price of $18.54 per share. The transaction generated total proceeds of $640,278.90.
Key Transaction Highlights
- Insider: Lauren Rusckowski Duprey, Chief Transformation Officer
- Security: American Depositary Shares (ADSs)
- Shares Disposed: 34,535 shares
- Execution Price: $18.54
- Post-Transaction Holdings: 191,522 shares (retaining approximately 84.7% of previous direct holdings)
- Rule 10b5-1 Plan: Not indicated as executed under a Rule 10b5-1 trading plan
Significance & Market Impact
The transaction represents a partial liquidation (~15.3% of holdings), with the executive retaining a substantial equity stake of 191,522 ADSs valued at over $3.5M at current price levels. As such, the transaction is categorized as having Medium trading significance.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.